You are subscribed to the Formulary News Capsule.

Formulary

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

June 7, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

Today's Headlines

Endometrial cancer patients reduced chance of death with statins, aspirin

Endometrial cancer patients reduced their chance of death by 84% with the use of statins and aspirin, according to a new study by researchers at Montefiore Einstein Center for Cancer Care (MECCC), presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Additionally, women who used only statins saw their risk of dying decline by 45%. » Full article

Crizotinib versus standard chemo

In a phase 3 study of previously treated patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), crizotinib (Xalkori, Pfizer) more than doubled median progression free survival (PFS) than when treated with standard chemotherapy, according to a study published June 1, 2013 online in New England Journal of Medicine. » Full article

New FDA MedWatch tools

As it celebrates the 20th anniversary of its MedWatch program, FDA has launched two new tools designed to make it easier for consumers and healthcare professionals to report product information to the agency. » Full article

Pharmacist-directed inpatient anticoagulation service

Implementation of a pharmacy service that provides dosing, monitoring, education, and ensured safe transition from the inpatient to the outpatient setting is associated with improved patient satisfaction with overall care and with care related to anticoagulation management, according to a study published in the Annals of Pharmacotherapy. » Full article

Continuing Education

Pain Management CPE: May activity available now

Welcome to our CPE series: Pain Management Considerations for Medication Therapy Management, which has been designed for pharmacists who take care of patients who need pain relief. You can earn up to 10 credits from April 2013 to August 2013 with 5 monthly knowledge-based activities and 2 credits from September 2013 to October 2013 with 2 monthly interactive online case studies.

The May activity covers pharmacology and therapeutics of pain medications, focusing on non-opioid analgesics.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

EDITOR'S PICK

Standards of medical care in diabetes: Focus on updated recommendations in hospitalized patients

Although the prevalence of diabetes mellitus in hospitalized patients remains unknown, an estimated one-fourth of inpatients experience hyperglycemia. Hyperglycemia is linked to poor health outcomes, and there is evidence that intensive glucose control in the hospital reduces mortality, need for dialysis, infections, and length of stay. The American Diabetes Association publishes clinical practice guidelines annually, which offer clinicians, patients, researchers, and payers current, evidence-based recommendations on all components of diabetes care, general treatment goals, and tools to evaluate the quality of care. The updated guidelines focus on changes in the recommendations for care of the hospitalized diabetes patient. » Full article

 

Related Articles

New oral contraceptives increase women’s cardiac risk

Study confirms low testosterone in crizotinib patients

Injectable methotrexate recalled

Web-based anticoagulation program

SURVEY

With several anti-obesity drugs recently introduced, and others in the near-term pipeline, what is the most appropriate managed care coverage policy for these products?

 

Should not be covered due to lack of long-term durability/safety data

Should be covered from day 1 for those meeting pre-determined BMI thresholds

Retroactively covered only for those sustaining a target weight loss at 1 yr

They should be covered without restriction

Click Here to let us know.

RESOURCES

Drug Watch

Latest Clinical News

 
Powered by Modern Medicine Advanstar Medical Communications Group